News Results

There are 778,227 News Results

Dec 2, 2024
PG&E Corporation Announces Launch of Concurrent Offerings of Common Stock and Mandatory Convertible Preferred Stock
OAKLAND, Calif., Dec. 2, 2024 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) ("PG&E" or the "Company") announced today the launch of concurrent underwritten public offerings of (i) $1,200 million of shares...
Dec 2, 2024
PG&E Corporation Announces Pricing of Concurrent Offerings of Common Stock and Mandatory Convertible Preferred Stock
OAKLAND, Calif., Dec. 2, 2024 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) ("PG&E" or the "Company") announced today the pricing of its previously announced concurrent underwritten public offerings of (i) 48,661,800...
Dec 12, 2024
Ryvu Therapeutics provides an update on RVU120 Phase II program
KRAKOW, Poland, Dec. 12, 2024 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, provided an...
Dec 13, 2024
ADC Contract Manufacturing Market Industry Report 2024 - Currently 30+ Manufacturers Claim to have the Required Capabilities to Offer Contract Manufacturing and Conjugation Services for ADCs Worldwide - ResearchAndMarkets.com
The "ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type...
Jan 8, 2025
Neurocrine Biosciences Announces Publication on Traditional Glucocorticoid Treatment in Classic Congenital Adrenal Hyperplasia in Expert Review of Endocrinology & Metabolism
-- Narrative Review Assesses Current Treatment Challenges and the Evolving Classic Congenital Adrenal Hyperplasia (CAH) Therapeutic Landscape -- Non-Glucocorticoid (GC) Mechanisms for Treatment of CAH Could Enable Control of Excess...
Jan 21, 2025
Neurocrine Biosciences Announces Classic Congenital Adrenal Hyperplasia Supplement Published Today in The Journal of Clinical Endocrinology & Metabolism
SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced publication of a classic congenital adrenal hyperplasia (CAH)-focused supplement in
Jan 28, 2025
Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by nanotechnology focus, AI-driven market transformation - Technavio
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope market size is estimated to grow by USD 528.8...
Jan 31, 2025
NAND Flash Market to Grow by USD 26.4 Billion (2025-2029), Boosted by Investments in Fabrication Facilities, with AI Impacting Market Trends - Technavio
NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global nand flash market size is estimated to grow by USD 26.4 billion...
Feb 14, 2025
Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
CRANFORD, N.J., Feb. 14, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted...
Mar 27, 2025
Massimo Group Reports Fiscal Year End 2024 Financial Results
GARLAND, Texas, March 27, 2025 /PRNewswire/ --
77823

Pages

1

Stories of the day

Oct 3, 2025
Blighter Wins Contract from South East Asian Military for Smart and Scalable...
Oct 3, 2025
Denmark Deploys Terma’s Integrated Counter-UAS solution Across Strategic Sites
Oct 3, 2025
BAE Systems and Forterra join forces to develop autonomous Armored Multi-...
Oct 3, 2025
Oshkosh Defense Highlights U.S. Army Modernization with $89 Million PLS A2 Award